Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Solid Tumor × Cefixime × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neuroblastoma 2 Solid Tumors 1 Solid Tumor 1 Relapsed Solid Tumors 1 Drug-Related Side Effects and Adverse Reactions 1 Diarrhea 1

Interventions

Fluorodeoxyglucose F18 7 Irinotecan 4 Fluorouracil 4 Bevacizumab 4 pembrolizumab 3 olaparib 3 Radiosurgery 3 Cyclophosphamide 3 Cisplatin 3 Capecitabine 3 vistusertib 2 toripalimab 2 tislelizumab 2 spartalizumab 2 fludarabine 2 atezolizumab 2 apatinib 2 Temozolomide 2 Radiotherapy 2 Proton Therapy 2 Paclitaxel 2 Leucovorin 2 Letrozole 2 Hydroxychloroquine 2 Everolimus 2 Drug Therapy 2 Docetaxel 2 tumor-cells apoptosis factor, human 1 trifluridine tipiracil drug combination 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00786669 2021-02-10

VITAC

Children's Hospital Medical Center, Cincinnati

Phase 1 Completed

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡